This topic contains a solution. Click here to go to the answer

Author Question: If long-run average costs are falling, then the firm is experiencing diseconomies of scale. ... (Read 72 times)

mspears3

  • Hero Member
  • *****
  • Posts: 586
If long-run average costs are falling, then the firm is experiencing diseconomies of scale.
  Indicate whether the statement is true or false

Question 2

Is wage discrimination more likely or less likely in competitive markets?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

srodz

  • Sr. Member
  • ****
  • Posts: 333
Answer to Question 1

False

Answer to Question 2

Competitive firms that discriminate may have to pay a higher wage than firms that do not discriminate. Since their costs are higher, they will have difficulty surviving in the long run in a highly competitive market. Other firms, which hire lower cost labor, will be able to undercut the output prices of wage-discriminating firms.




mspears3

  • Member
  • Posts: 586
Reply 2 on: Jun 30, 2018
Great answer, keep it coming :)


Bigfoot1984

  • Member
  • Posts: 321
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Every 10 seconds, a person in the United States goes to the emergency room complaining of head pain. About 1.2 million visits are for acute migraine attacks.

Did you know?

Amoebae are the simplest type of protozoans, and are characterized by a feeding and dividing trophozoite stage that moves by temporary extensions called pseudopodia or false feet.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

Did you know?

The senior population grows every year. Seniors older than 65 years of age now comprise more than 13% of the total population. However, women outlive men. In the 85-and-over age group, there are only 45 men to every 100 women.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library